SCHEMBL16720047

SCHEMBL16720047

CC(C)(O)n1ccc2cc[c]cc21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16720241 0.85 — —
SCHEMBL16720365 0.81 — —
SCHEMBL686703 0.72 CYP2A6 (0.40) —
SCHEMBL16720401 0.70 — —
SCHEMBL18227585 0.70 — —
SCHEMBL16719574 0.69 — —
SCHEMBL3211956 0.69 NOTUM (0.58) —
SCHEMBL2365253 0.68 CDK4 (0.35) —
SCHEMBL6986127 0.68 — —
SCHEMBL18230328 0.68 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3068758-A1 EBNA1 INHIBITORS AND THEIR METHOD OF USE The Wistar Institute Of Anatomy And Biology (US) 2016-09-21 — — EP disclosed
WO-2015073864-A1 EBNA1 INHIBITORS AND THEIR METHOD OF USE THE WISAR INSTITUTE OF ANATOMY AND BIOLOGY (US) 2015-05-21 — — WO disclosed
Send feedback